Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis

The removal of degenerating myelin by phagocytosis is central to pathogenesis and repair in traumatized and diseased nervous system. Galectin-3/MAC-2 is a differentiation and activation marker of murine and human monocytes/macrophages/microglia. Galectin-3/MAC-2, along with MAC-1 that mediates myeli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 1999-12, Vol.160 (2), p.508-514
Hauptverfasser: Reichert, Fanny, Rotshenker, Shlomo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 514
container_issue 2
container_start_page 508
container_title Experimental neurology
container_volume 160
creator Reichert, Fanny
Rotshenker, Shlomo
description The removal of degenerating myelin by phagocytosis is central to pathogenesis and repair in traumatized and diseased nervous system. Galectin-3/MAC-2 is a differentiation and activation marker of murine and human monocytes/macrophages/microglia. Galectin-3/MAC-2, along with MAC-1 that mediates myelin phagocytosis, marks an in vivo activation state in macrophages, which are involved in myelin degeneration and phagocytosis in injured mouse peripheral nerves. In contrast, high levels of MAC-1 but extremely low levels of Galectin-3/MAC-2 are expressed in vivo in injured CNS where myelin degeneration and phagocytosis progress extremely slowly. The present study was aimed at testing whether an activation state marked by Galectin-3/MAC-2 is present in vivo in the CNS of EAE mice concomitant with autoimmune induced myelin degeneration and phagocytosis. EAE was inflicted by mouse spinal cord homogenate. Demyelination was assessed by light microscopy and Galectin-3/MAC-2, MAC-1, and F4/80 expression by immunocytochemistry. We presently document that Galectin-3/MAC-2 expression is up regulated, along with MAC-1 and F4/80, in spinal cords and optic nerves of EAE mice in areas of demyelination and myelin degeneration, in myelin phagocytosing microglia and macrophages. Copolymer 1 (Glatiramer acetate) suppresses EAE, demyelination, and Galectin-3/MAC-2 expression. EAE pathogenesis thus involves a state of activation in microglia and macrophages characterized by the expression Galectin-3/MAC-2 along with MAC-1. Furthermore, the in vivo responses to injury and autoimmune challenge in the CNS differ in the activation pattern of microglia and macrophages with regard to Galectin-3/MAC-2 expression and the corresponding occurrence of myelin degeneration and phagocytosis.
doi_str_mv 10.1006/exnr.1999.7229
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69384885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488699972291</els_id><sourcerecordid>69384885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-81fbf411bfed222cd2b32fce6db61cb466d07d9a846bb7ac8bc4f1338ed59bb3</originalsourceid><addsrcrecordid>eNp1kD1PwzAURS0EoqWwMqIOiC2t7biOLaaqKgWpiKW75Y8XMHKTYKeo_fckaiVYmN5y3tW9B6FbgicEYz6FfRUnREo5KSiVZ2hIsMQZZTk-R0OMCcuYEHyArlL6xBhLRotLNCCYEznjYogeVzqAbX2V5dPX-SKjY1-Nl_sGot9C1eownocA8d3b8bKy0HzoUG8PEHzr0zW6KHVIcHO6I7R5Wm4Wz9n6bfWymK8zm3PZZoKUpmSEmBIcpdQ6anJaWuDOcGIN49zhwkktGDem0FYYy0qS5wLcTBqTj9DDMbaJ9dcOUqu2PlkIQVdQ75LiMhfdyFkHTo6gjXVKEUrVdCt0PCiCVW9L9bZUb0v1trqHu1PyzmzB_cGPejrg_gToZHUoo66sT78cnTHB-hxxxKCz8O0hqmQ9dLqcj51c5Wr_X4Uf7euGAQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69384885</pqid></control><display><type>article</type><title>Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Reichert, Fanny ; Rotshenker, Shlomo</creator><creatorcontrib>Reichert, Fanny ; Rotshenker, Shlomo</creatorcontrib><description>The removal of degenerating myelin by phagocytosis is central to pathogenesis and repair in traumatized and diseased nervous system. Galectin-3/MAC-2 is a differentiation and activation marker of murine and human monocytes/macrophages/microglia. Galectin-3/MAC-2, along with MAC-1 that mediates myelin phagocytosis, marks an in vivo activation state in macrophages, which are involved in myelin degeneration and phagocytosis in injured mouse peripheral nerves. In contrast, high levels of MAC-1 but extremely low levels of Galectin-3/MAC-2 are expressed in vivo in injured CNS where myelin degeneration and phagocytosis progress extremely slowly. The present study was aimed at testing whether an activation state marked by Galectin-3/MAC-2 is present in vivo in the CNS of EAE mice concomitant with autoimmune induced myelin degeneration and phagocytosis. EAE was inflicted by mouse spinal cord homogenate. Demyelination was assessed by light microscopy and Galectin-3/MAC-2, MAC-1, and F4/80 expression by immunocytochemistry. We presently document that Galectin-3/MAC-2 expression is up regulated, along with MAC-1 and F4/80, in spinal cords and optic nerves of EAE mice in areas of demyelination and myelin degeneration, in myelin phagocytosing microglia and macrophages. Copolymer 1 (Glatiramer acetate) suppresses EAE, demyelination, and Galectin-3/MAC-2 expression. EAE pathogenesis thus involves a state of activation in microglia and macrophages characterized by the expression Galectin-3/MAC-2 along with MAC-1. Furthermore, the in vivo responses to injury and autoimmune challenge in the CNS differ in the activation pattern of microglia and macrophages with regard to Galectin-3/MAC-2 expression and the corresponding occurrence of myelin degeneration and phagocytosis.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1006/exnr.1999.7229</identifier><identifier>PMID: 10619568</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Animals ; Antigens, Differentiation - analysis ; Antigens, Differentiation - metabolism ; Biological and medical sciences ; CR3 ; Crosses, Genetic ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; EAE ; Encephalomyelitis, Autoimmune, Experimental - metabolism ; Encephalomyelitis, Autoimmune, Experimental - pathology ; Female ; Galectin 3 ; Galectin-3/MAC-2 ; Glatiramer acetate/copolymer 1 ; Humans ; Immunohistochemistry ; MAC-1 ; Macrophage-1 Antigen - metabolism ; macrophage/microglia ; Macrophages - metabolism ; Macrophages - pathology ; Male ; Medical sciences ; Membrane Glycoproteins - metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Inbred Strains ; multiple sclerosis ; Myelin Sheath - pathology ; Nerve Degeneration ; Neurology ; Optic Nerve - metabolism ; Optic Nerve - pathology ; Phagocytosis ; Spinal Cord - immunology ; Spinal Cord - metabolism ; Spinal Cord - pathology</subject><ispartof>Experimental neurology, 1999-12, Vol.160 (2), p.508-514</ispartof><rights>1999 Academic Press</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-81fbf411bfed222cd2b32fce6db61cb466d07d9a846bb7ac8bc4f1338ed59bb3</citedby><cites>FETCH-LOGICAL-c369t-81fbf411bfed222cd2b32fce6db61cb466d07d9a846bb7ac8bc4f1338ed59bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014488699972291$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1254849$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10619568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reichert, Fanny</creatorcontrib><creatorcontrib>Rotshenker, Shlomo</creatorcontrib><title>Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>The removal of degenerating myelin by phagocytosis is central to pathogenesis and repair in traumatized and diseased nervous system. Galectin-3/MAC-2 is a differentiation and activation marker of murine and human monocytes/macrophages/microglia. Galectin-3/MAC-2, along with MAC-1 that mediates myelin phagocytosis, marks an in vivo activation state in macrophages, which are involved in myelin degeneration and phagocytosis in injured mouse peripheral nerves. In contrast, high levels of MAC-1 but extremely low levels of Galectin-3/MAC-2 are expressed in vivo in injured CNS where myelin degeneration and phagocytosis progress extremely slowly. The present study was aimed at testing whether an activation state marked by Galectin-3/MAC-2 is present in vivo in the CNS of EAE mice concomitant with autoimmune induced myelin degeneration and phagocytosis. EAE was inflicted by mouse spinal cord homogenate. Demyelination was assessed by light microscopy and Galectin-3/MAC-2, MAC-1, and F4/80 expression by immunocytochemistry. We presently document that Galectin-3/MAC-2 expression is up regulated, along with MAC-1 and F4/80, in spinal cords and optic nerves of EAE mice in areas of demyelination and myelin degeneration, in myelin phagocytosing microglia and macrophages. Copolymer 1 (Glatiramer acetate) suppresses EAE, demyelination, and Galectin-3/MAC-2 expression. EAE pathogenesis thus involves a state of activation in microglia and macrophages characterized by the expression Galectin-3/MAC-2 along with MAC-1. Furthermore, the in vivo responses to injury and autoimmune challenge in the CNS differ in the activation pattern of microglia and macrophages with regard to Galectin-3/MAC-2 expression and the corresponding occurrence of myelin degeneration and phagocytosis.</description><subject>Animals</subject><subject>Antigens, Differentiation - analysis</subject><subject>Antigens, Differentiation - metabolism</subject><subject>Biological and medical sciences</subject><subject>CR3</subject><subject>Crosses, Genetic</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>EAE</subject><subject>Encephalomyelitis, Autoimmune, Experimental - metabolism</subject><subject>Encephalomyelitis, Autoimmune, Experimental - pathology</subject><subject>Female</subject><subject>Galectin 3</subject><subject>Galectin-3/MAC-2</subject><subject>Glatiramer acetate/copolymer 1</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>MAC-1</subject><subject>Macrophage-1 Antigen - metabolism</subject><subject>macrophage/microglia</subject><subject>Macrophages - metabolism</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred Strains</subject><subject>multiple sclerosis</subject><subject>Myelin Sheath - pathology</subject><subject>Nerve Degeneration</subject><subject>Neurology</subject><subject>Optic Nerve - metabolism</subject><subject>Optic Nerve - pathology</subject><subject>Phagocytosis</subject><subject>Spinal Cord - immunology</subject><subject>Spinal Cord - metabolism</subject><subject>Spinal Cord - pathology</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAURS0EoqWwMqIOiC2t7biOLaaqKgWpiKW75Y8XMHKTYKeo_fckaiVYmN5y3tW9B6FbgicEYz6FfRUnREo5KSiVZ2hIsMQZZTk-R0OMCcuYEHyArlL6xBhLRotLNCCYEznjYogeVzqAbX2V5dPX-SKjY1-Nl_sGot9C1eownocA8d3b8bKy0HzoUG8PEHzr0zW6KHVIcHO6I7R5Wm4Wz9n6bfWymK8zm3PZZoKUpmSEmBIcpdQ6anJaWuDOcGIN49zhwkktGDem0FYYy0qS5wLcTBqTj9DDMbaJ9dcOUqu2PlkIQVdQ75LiMhfdyFkHTo6gjXVKEUrVdCt0PCiCVW9L9bZUb0v1trqHu1PyzmzB_cGPejrg_gToZHUoo66sT78cnTHB-hxxxKCz8O0hqmQ9dLqcj51c5Wr_X4Uf7euGAQ</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>Reichert, Fanny</creator><creator>Rotshenker, Shlomo</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis</title><author>Reichert, Fanny ; Rotshenker, Shlomo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-81fbf411bfed222cd2b32fce6db61cb466d07d9a846bb7ac8bc4f1338ed59bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Antigens, Differentiation - analysis</topic><topic>Antigens, Differentiation - metabolism</topic><topic>Biological and medical sciences</topic><topic>CR3</topic><topic>Crosses, Genetic</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>EAE</topic><topic>Encephalomyelitis, Autoimmune, Experimental - metabolism</topic><topic>Encephalomyelitis, Autoimmune, Experimental - pathology</topic><topic>Female</topic><topic>Galectin 3</topic><topic>Galectin-3/MAC-2</topic><topic>Glatiramer acetate/copolymer 1</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>MAC-1</topic><topic>Macrophage-1 Antigen - metabolism</topic><topic>macrophage/microglia</topic><topic>Macrophages - metabolism</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred Strains</topic><topic>multiple sclerosis</topic><topic>Myelin Sheath - pathology</topic><topic>Nerve Degeneration</topic><topic>Neurology</topic><topic>Optic Nerve - metabolism</topic><topic>Optic Nerve - pathology</topic><topic>Phagocytosis</topic><topic>Spinal Cord - immunology</topic><topic>Spinal Cord - metabolism</topic><topic>Spinal Cord - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reichert, Fanny</creatorcontrib><creatorcontrib>Rotshenker, Shlomo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reichert, Fanny</au><au>Rotshenker, Shlomo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>160</volume><issue>2</issue><spage>508</spage><epage>514</epage><pages>508-514</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>The removal of degenerating myelin by phagocytosis is central to pathogenesis and repair in traumatized and diseased nervous system. Galectin-3/MAC-2 is a differentiation and activation marker of murine and human monocytes/macrophages/microglia. Galectin-3/MAC-2, along with MAC-1 that mediates myelin phagocytosis, marks an in vivo activation state in macrophages, which are involved in myelin degeneration and phagocytosis in injured mouse peripheral nerves. In contrast, high levels of MAC-1 but extremely low levels of Galectin-3/MAC-2 are expressed in vivo in injured CNS where myelin degeneration and phagocytosis progress extremely slowly. The present study was aimed at testing whether an activation state marked by Galectin-3/MAC-2 is present in vivo in the CNS of EAE mice concomitant with autoimmune induced myelin degeneration and phagocytosis. EAE was inflicted by mouse spinal cord homogenate. Demyelination was assessed by light microscopy and Galectin-3/MAC-2, MAC-1, and F4/80 expression by immunocytochemistry. We presently document that Galectin-3/MAC-2 expression is up regulated, along with MAC-1 and F4/80, in spinal cords and optic nerves of EAE mice in areas of demyelination and myelin degeneration, in myelin phagocytosing microglia and macrophages. Copolymer 1 (Glatiramer acetate) suppresses EAE, demyelination, and Galectin-3/MAC-2 expression. EAE pathogenesis thus involves a state of activation in microglia and macrophages characterized by the expression Galectin-3/MAC-2 along with MAC-1. Furthermore, the in vivo responses to injury and autoimmune challenge in the CNS differ in the activation pattern of microglia and macrophages with regard to Galectin-3/MAC-2 expression and the corresponding occurrence of myelin degeneration and phagocytosis.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>10619568</pmid><doi>10.1006/exnr.1999.7229</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 1999-12, Vol.160 (2), p.508-514
issn 0014-4886
1090-2430
language eng
recordid cdi_proquest_miscellaneous_69384885
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antigens, Differentiation - analysis
Antigens, Differentiation - metabolism
Biological and medical sciences
CR3
Crosses, Genetic
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
EAE
Encephalomyelitis, Autoimmune, Experimental - metabolism
Encephalomyelitis, Autoimmune, Experimental - pathology
Female
Galectin 3
Galectin-3/MAC-2
Glatiramer acetate/copolymer 1
Humans
Immunohistochemistry
MAC-1
Macrophage-1 Antigen - metabolism
macrophage/microglia
Macrophages - metabolism
Macrophages - pathology
Male
Medical sciences
Membrane Glycoproteins - metabolism
Mice
Mice, Inbred BALB C
Mice, Inbred Strains
multiple sclerosis
Myelin Sheath - pathology
Nerve Degeneration
Neurology
Optic Nerve - metabolism
Optic Nerve - pathology
Phagocytosis
Spinal Cord - immunology
Spinal Cord - metabolism
Spinal Cord - pathology
title Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A20%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Galectin-3/MAC-2%20in%20Experimental%20Allergic%20Encephalomyelitis&rft.jtitle=Experimental%20neurology&rft.au=Reichert,%20Fanny&rft.date=1999-12-01&rft.volume=160&rft.issue=2&rft.spage=508&rft.epage=514&rft.pages=508-514&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1006/exnr.1999.7229&rft_dat=%3Cproquest_cross%3E69384885%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69384885&rft_id=info:pmid/10619568&rft_els_id=S0014488699972291&rfr_iscdi=true